Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Thermo Fisher Scientific Extends Reach in Pharma, Biotech with PPD Acquisition

Facebook Twitter LinkedIn Email
WALTHAM, Mass., April 15, 2021 — Thermo Fisher Scientific is acquiring PPD Inc., a provider of clinical research services to the pharma and biotech industry. The companies’ boards of directors approved an acquisition agreement worth $17.4 billion and $47.50 per share, as well as Thermo Fisher’s assumption of approximately $3.5 billion of net debt. PPD will become part of Thermo Fisher’s laboratory products and services segment.

In a press release, Thermo Fisher said the acquisition provides it with a drug development platform, patient recruitment capabilities, and laboratory services, supporting its capabilities in pharma and biotech.

The transaction is expected to close by the end of 2021.
Apr 2021
mergers & acquisitionsacquisitionsThermo FisherThermo Fisher ScientificThermo Fisher Scientific Inc.Americaslife sciencesmedicalmedical instrumentationmedicineBiophotonicsbiotechpharma

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.